The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - BioCad (I)
Research Funding - BioCad
Phase II trial (BCD-100-2/MIRACULUM) of the novel PD-1 inhibitor (BCD-100) in patients with advanced melanoma.
 
Sergey Fogt
Employment - BioCad
 
Mariia Shustova
Employment - BioCad
 
Lev V. Demidov
Honoraria - BioCad; Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - BioCad; Bristol-Myers Squibb
Research Funding - BioCad; Novartis
 
Vladimir Moiseyenko
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Speakers' Bureau - AstraZeneca; BioCad; Lilly; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Roche
 
Tatiana Semiglazova
No Relationships to Disclose
 
Svetlana Protsenko
Honoraria - BioCad
Research Funding - BioCad
 
Svetlana Odintsova
Honoraria - BioCad
Research Funding - BioCad
 
Ruslan Zukov
Research Funding - BioCad
 
Sergey Lazarev
Research Funding - BioCad
 
Yuliya Makarova
Research Funding - BioCad
 
Marina Nechaeva
Research Funding - BioCad
 
Dina Sakaeva
Honoraria - BioCad
Research Funding - BioCad
 
Aleksey Andreev
Research Funding - BioCad
 
Anna Tarasova
Research Funding - BioCad
 
Natalia Fadeeva
Research Funding - BioCad
 
Olesya Gavrilova
Employment - BioCad
 
Roman Ivanov
Employment - BioCad
Leadership - BioCad